Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2022-10-01
2024-03-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
32 sedentary individuals between the ages of 65-80 participated in the study. Nordic Walking (NW) and Traditional Walking (GY) groups were created by systematic randomization method. In line with the intended research parameters, participants were given 30 sec sit-to-stand (30secCST), 30 sec biceps curl (30 sec ACT), timed up and go (TUG) 6 min walk (6MWT), Tinetti Fall Effectiveness (Tinetti FES), Tampa Kinesiophobia Scale (TSK), World Health Organization Quality of Life Elderly Module (WHOQOL-Old) were administered. Evaluations were repeated before and after the study. The study was conducted under the supervision of a physiotherapist, 3 days a week for 12 weeks in both groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Effects of Green Exercise Programs Including Resistance and Aerobic Exercises
NCT05958745
Comparison of the Effectiveness of Different Home Exercise Programs
NCT03878394
Effect Of Functional Balance Exercise İn Elderly
NCT06383676
Comparison of the Effects of Different Living Environments in Geriatric Individuals: A Pilot Study
NCT04873791
Physical Function From the Perspective of Active Ageing
NCT06733818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Nordic Walking
nordic walking
Before the NW program, participants completed a one-week familiarization phase to practice pole use. Training was held three times: 15 minutes on days 1 and 2, and 20 minutes on day 3, at 40-60% heart rate reserve (measured with a pulse oximeter). Warm-up included a 1-minute slow walk, toe raises, seated dorsiflexion, mini squats, scapular adduction, and shoulder/wrist stretches. Each session ended with a cool-down of a 2-minute slow walk and 20-second stretches for major muscle groups (quadriceps, hamstrings, lumbar extensors, gastrocnemius, shoulders, wrists).The walking poles used in this study were the Evolite Ultralite Titanium Antishock Trekking Pole, which has a titanium alloy body and a three-piece telescopic structure, adjustable to the desired length between 68 and 135 cm.
Control
General walking
General walking
The program was performed on concrete or compacted soil surfaces, under the same physiotherapist's supervision. Walking speed was adjusted to remain below 60% of maximal heart rate and to allow participants to converse comfortably during exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nordic walking
Before the NW program, participants completed a one-week familiarization phase to practice pole use. Training was held three times: 15 minutes on days 1 and 2, and 20 minutes on day 3, at 40-60% heart rate reserve (measured with a pulse oximeter). Warm-up included a 1-minute slow walk, toe raises, seated dorsiflexion, mini squats, scapular adduction, and shoulder/wrist stretches. Each session ended with a cool-down of a 2-minute slow walk and 20-second stretches for major muscle groups (quadriceps, hamstrings, lumbar extensors, gastrocnemius, shoulders, wrists).The walking poles used in this study were the Evolite Ultralite Titanium Antishock Trekking Pole, which has a titanium alloy body and a three-piece telescopic structure, adjustable to the desired length between 68 and 135 cm.
General walking
The program was performed on concrete or compacted soil surfaces, under the same physiotherapist's supervision. Walking speed was adjusted to remain below 60% of maximal heart rate and to allow participants to converse comfortably during exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having a score of 24 or above on the Standardized Mini-Mental State Examination (SMMSE),
* and voluntarily agreeing to participate in the study.
Exclusion Criteria
* acute retinal hemorrhage or previous ophthalmic surgery,
* active infection, malignancy,
* multiple organ failure, terminal illness, or a history of lower or upper extremity fracture within the last three months.
* had any musculoskeletal condition that would prevent them from engaging in exercise,
* a diagnosis of Alzheimer's disease, Parkinson's disease, or dementia,
* a diagnosis of benign paroxysmal positional vertigo (BPPV),
* had engaged in regular exercise training (≥150 minutes per week) within the past six months.
65 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Rumeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nursel Oziri
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Öziri
Ataşehir, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstanbulRumeliU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.